staurosporine has been researched along with Hodgkin Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holtick, U; Horn, F; Kube, D; Kussebi, N; Lauber, K; Löffler, D; Pinkert, D; Schoof, N; Stürzenhofecker, B; Trümper, L; Vockerodt, M; Wesselborg, S | 1 |
Jürgensmeier, JM; Kashkar, H; Krönke, M | 1 |
2 other study(ies) available for staurosporine and Hodgkin Disease
Article | Year |
---|---|
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
Topics: Apoptosis; Cell Division; DNA-Binding Proteins; Enzyme Inhibitors; fas Receptor; Gene Expression; Hodgkin Disease; Humans; Jurkat Cells; Nitriles; Phosphorylation; Protein Kinase Inhibitors; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Staurosporine; Trans-Activators; Tyrphostins | 2005 |
Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis.
Topics: Apoptosis; B-Lymphocytes; bcl-2-Associated X Protein; Caspase 3; Caspases; Drug Resistance; Enzyme Activation; Enzyme Inhibitors; Hodgkin Disease; Humans; Mitochondria; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Staurosporine; Tumor Cells, Cultured | 2002 |